tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Rhythm Pharmaceuticals Inc

RYTM
Add to Watchlist
99.250USD
-6.490-6.14%
Close 07-31 16:00（ET）Quotes delayed by 15 min
6.79BMarket Cap
LossP/E TTM

Rhythm Pharmaceuticals Inc

99.250
-6.490-6.14%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

RYTM Financials

See Rhythm Pharmaceuticals Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Rhythm Pharmaceuticals Inc Earnings Date

Latest Release
Aug 4, 2026
EPS / Forecast
--/-0.82
Revenue / Forecast
--/67.28M
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
189.76M
45.83%
EPS(YoY)
-3.11
28.37%
Analyst Rating
BUY
2026/08/01
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-3.58%-0.83
-0.76%-0.73
-11.52%-0.82
-36.96%-0.75
65.71%-0.81
-3.07%-0.72
3.74%-0.73
33.02%-0.55
-155.46%-2.35
6.79%-0.70
---0.76
---0.82
---0.92
---0.75
---2.73
----
----
----
----
----
Revenue
83.81%60.11M
36.87%57.25M
54.28%51.30M
66.80%48.50M
25.94%32.70M
72.61%41.83M
47.76%33.25M
51.28%29.08M
126.41%25.97M
175.70%24.23M
425.30%22.50M
112.01%19.22M
665.62%11.47M
383.76%8.79M
316.73%4.28M
3208.76%9.07M
4180.00%1.50M
--1.82M
--1.03M
--274.00K
Net Profit
-11.65%-56.74M
-9.42%-48.84M
-20.70%-54.28M
-42.96%-47.98M
64.05%-50.82M
-7.20%-44.63M
-1.83%-44.97M
28.14%-33.56M
-170.94%-141.37M
2.02%-41.63M
-8.08%-44.16M
-3.78%-46.70M
1.11%-52.18M
0.87%-42.49M
-16.39%-40.86M
-27.16%-45.00M
-220.60%-52.76M
-22.84%-42.87M
-3.81%-35.11M
-13.73%-35.39M
Net Margin
38.85%-92.56%
19.83%-82.97%
21.42%-103.13%
13.34%-96.14%
72.20%-151.35%
39.76%-103.50%
33.12%-131.25%
54.34%-110.95%
-19.67%-544.43%
64.46%-171.80%
---196.25%
---242.98%
---454.96%
---483.42%
---933.63%
----
----
----
----
----
Gross Margin
-0.85%88.09%
0.73%91.61%
0.90%89.28%
-1.44%88.57%
-0.39%88.85%
4.95%90.95%
-0.89%88.49%
1.70%89.87%
1.80%89.19%
-1.86%86.66%
--89.28%
--88.37%
--87.61%
--88.30%
--92.56%
----
----
----
----
----
Debt to assets ratio
-13.42%24.52%
-19.52%22.53%
-28.45%21.50%
3.79%29.46%
-31.77%28.32%
-12.24%27.99%
1.65%30.05%
10.86%28.38%
85.11%41.51%
60.94%31.90%
--29.56%
--25.60%
--22.43%
--19.82%
--18.73%
----
----
----
----
----
Income Statement
Revenue
83.81%60.11M
36.87%57.25M
54.28%51.30M
66.80%48.50M
25.94%32.70M
72.61%41.83M
47.76%33.25M
51.28%29.08M
126.41%25.97M
175.70%24.23M
425.30%22.50M
112.01%19.22M
665.62%11.47M
383.76%8.79M
316.73%4.28M
3208.76%9.07M
4180.00%1.50M
--1.82M
--1.03M
--274.00K
Operating profit
-11.40%-52.36M
-14.08%-47.06M
-19.98%-52.65M
-11.90%-45.30M
66.40%-47.00M
0.02%-41.26M
0.15%-43.88M
13.14%-40.48M
-166.29%-139.89M
1.99%-41.27M
-11.93%-43.95M
-3.34%-46.60M
0.30%-52.53M
17.43%-42.10M
11.24%-39.27M
-11.54%-45.10M
-53.18%-52.69M
-45.38%-50.99M
-29.04%-44.24M
-26.67%-40.43M
Net Profit
-11.65%-56.74M
-9.42%-48.84M
-20.70%-54.28M
-42.96%-47.98M
64.05%-50.82M
-7.20%-44.63M
-1.83%-44.97M
28.14%-33.56M
-170.94%-141.37M
2.02%-41.63M
-8.08%-44.16M
-3.78%-46.70M
1.11%-52.18M
0.87%-42.49M
-16.39%-40.86M
-27.16%-45.00M
-220.60%-52.76M
-22.84%-42.87M
-3.81%-35.11M
-13.73%-35.39M
Balance Sheet
Current assets
16.46%430.09M
24.78%466.92M
45.38%494.80M
0.93%360.68M
56.64%369.29M
21.39%374.20M
3.38%340.34M
25.89%357.37M
-25.83%235.75M
-12.98%308.27M
-9.03%329.20M
13.86%283.88M
25.41%317.84M
14.87%354.24M
7.82%361.87M
-34.12%249.33M
-38.50%253.45M
69.75%308.39M
59.89%335.64M
59.14%378.45M
Total current liabilities
-7.71%103.20M
-8.29%105.94M
6.83%104.27M
136.57%129.46M
106.47%111.82M
109.26%115.52M
94.65%97.61M
18.70%54.72M
17.66%54.16M
38.67%55.20M
51.50%50.14M
3.44%46.10M
-2.63%46.03M
-8.33%39.81M
41.04%33.10M
155.28%44.57M
180.56%47.27M
141.34%43.43M
48.08%23.47M
17.14%17.46M
Total assets
14.39%442.32M
22.41%480.20M
39.42%506.87M
-2.39%372.73M
49.50%386.69M
17.89%392.27M
2.65%363.57M
23.20%381.85M
-25.18%258.65M
-13.00%332.75M
-9.09%354.20M
11.62%309.94M
21.37%345.68M
16.07%382.48M
9.50%389.61M
-28.51%277.68M
-32.54%284.82M
76.15%329.52M
65.13%355.82M
59.51%388.39M
Total liabilities
-8.45%204.70M
-7.71%210.17M
0.15%211.19M
18.19%239.15M
13.46%223.60M
39.72%227.72M
34.55%210.88M
58.51%202.35M
56.51%197.07M
37.87%162.99M
44.55%156.72M
55.59%127.66M
156.68%125.92M
160.55%118.22M
223.06%108.42M
123.56%82.05M
18.89%49.05M
120.84%45.37M
81.01%33.56M
106.98%36.70M
Total equity
45.70%237.62M
64.10%270.03M
93.64%295.68M
-25.58%133.58M
164.84%163.09M
-3.07%164.55M
-22.68%152.70M
-1.53%179.50M
-71.98%61.58M
-35.76%169.76M
-29.77%197.47M
-6.82%182.28M
-6.79%219.76M
-7.00%264.26M
-12.74%281.19M
-44.37%195.63M
-38.11%235.77M
70.63%284.15M
63.64%322.26M
55.78%351.69M
Cash Flow Statement
Net operating income
-9.50%-44.19M
-34.73%-25.39M
-5.58%-26.62M
19.82%-23.31M
0.96%-40.35M
35.87%-18.84M
13.79%-25.22M
29.24%-29.08M
-11.83%-40.74M
13.58%-29.38M
37.75%-29.25M
-5.88%-41.09M
32.07%-36.43M
15.99%-34.00M
-17.00%-46.99M
-21.89%-38.81M
-59.95%-53.63M
-38.97%-40.47M
-48.58%-40.16M
-7.10%-31.84M
Net investment
129.94%57.05M
43.44%30.35M
-171.25%-246.35M
731.10%54.03M
-17.43%24.81M
-6.55%21.16M
4.36%-90.82M
-117.77%-8.56M
62.75%30.05M
155.52%22.64M
-139.21%-94.96M
33.94%48.19M
-74.54%18.46M
-662.57%-40.77M
-163.23%-39.70M
166.02%35.98M
149.77%72.52M
-88.29%7.25M
79.83%62.78M
-58.84%13.53M
Net financing
-116.62%-5.40M
-107.69%-2.95M
7496.35%189.30M
-100.61%-889.00K
665.94%32.50M
1481.84%38.33M
-96.59%2.49M
15248.08%146.18M
3290.23%4.24M
-86.05%2.42M
-53.93%73.04M
-102.57%-965.00K
-133.33%-133.00K
17265.00%17.36M
38293.22%158.56M
9691.12%37.50M
-99.76%399.00K
-76.19%100.00K
-40.92%413.00K
109.29%383.00K

FAQs

What is the total revenue of Rhythm Pharmaceuticals Inc?

According to Rhythm Pharmaceuticals Inc's FY2025 earnings report, its total revenue reached 189.76M, with a year-on-year change of 130.13M.

What are the current assets of Rhythm Pharmaceuticals Inc?

According to Rhythm Pharmaceuticals Inc's FY2025 earnings report, its current assets were 466.92M, with a year-on-year change of 24.78.

What are the total assets of Rhythm Pharmaceuticals Inc?

According to Rhythm Pharmaceuticals Inc's FY2025 earnings report, its total assets of Rhythm Pharmaceuticals Inc were 480.20M, with a year-on-year change of 22.41.

What are the total liabilities of Rhythm Pharmaceuticals Inc?

According to Rhythm Pharmaceuticals Inc's FY2025 earnings report, its total liabilities of Rhythm Pharmaceuticals Inc were 210.17M, with a year-on-year change of -7.71.

What is the total equity of Rhythm Pharmaceuticals Inc?

According to Rhythm Pharmaceuticals Inc's FY2025 earnings report, its total equity of Rhythm Pharmaceuticals Inc was 270.03M, with a year-on-year change of 64.10.

What is the net operating income of Rhythm Pharmaceuticals Inc?

According to Rhythm Pharmaceuticals Inc's FY2025 earnings report, its net operating income of Rhythm Pharmaceuticals Inc was -192.02M, with a year-on-year change of 27.68.

What is the net investment of Rhythm Pharmaceuticals Inc?

According to Rhythm Pharmaceuticals Inc's FY2025 earnings report, its net investment of Rhythm Pharmaceuticals Inc was -137.15M, with a year-on-year change of -184.71.

What is the net financing of Rhythm Pharmaceuticals Inc?

According to Rhythm Pharmaceuticals Inc's FY2025 earnings report, its net financing of Rhythm Pharmaceuticals Inc was 217.96M, with a year-on-year change of 13.97.

What is the Earnings Per Share (EPS) of Rhythm Pharmaceuticals Inc?

According to Rhythm Pharmaceuticals Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -3.11, with a year-on-year change of 28.37.

What is the net income of Rhythm Pharmaceuticals Inc?

According to Rhythm Pharmaceuticals Inc's FY2025 earnings report, its net income was -201.92M, with a year-on-year change of 23.68.

What is the net margin of Rhythm Pharmaceuticals Inc?

According to Rhythm Pharmaceuticals Inc's FY2025 earnings report, its net profit margin was -103.57, with a year-on-year change of 48.28.

What is the debt-to-asset ratio of Rhythm Pharmaceuticals Inc?

According to Rhythm Pharmaceuticals Inc's FY2025 earnings report, its debt-to-asset ratio was 22.53, with a year-on-year change of -19.52.

What is the Return on Equity (ROE) of Rhythm Pharmaceuticals Inc?

According to Rhythm Pharmaceuticals Inc's FY2025 earnings report, its Return on Equity (ROE) was -251.14, with a year-on-year change of 9.12.

What is the Return on Assets (ROA) of Rhythm Pharmaceuticals Inc?

According to Rhythm Pharmaceuticals Inc's FY2025 earnings report, its Return on Assets (ROA) was -45.05, with a year-on-year change of 37.33.

What is the operating profit of Rhythm Pharmaceuticals Inc?

According to Rhythm Pharmaceuticals Inc's FY2025 earnings report, its operating profit was -192.02M, with a year-on-year change of 27.68.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy